Trial · NCT02564926
Adverse events32
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 32
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Toothache | Gastrointestinal disorders | Dapagliflozin | 4 | 60 | 5 |
| other | Toothache | Gastrointestinal disorders | Glimepiride | 1 | 61 | 1 |
| other | Nasopharyngitis | Infections and infestations | Dapagliflozin | 4 | 60 | 4 |
| other | Nasopharyngitis | Infections and infestations | Glimepiride | 2 | 61 | 2 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Dapagliflozin | 3 | 60 | 3 |
| other | Hypoglycaemia | Metabolism and nutrition disorders | Glimepiride | 7 | 61 | 12 |
| serious | Pyelonephritis acute | Infections and infestations | Dapagliflozin | 0 | 60 | 0 |
| serious | Pyelonephritis acute | Infections and infestations | Glimepiride | 1 | 61 | 1 |
| serious | Ankle fracture | Injury, poisoning and procedural complications | Dapagliflozin | 0 | 60 | 0 |
| serious | Ankle fracture | Injury, poisoning and procedural complications | Glimepiride | 1 | 61 | 1 |
| serious | Joint dislocation | Injury, poisoning and procedural complications | Dapagliflozin | 0 | 60 | 0 |
| serious | Joint dislocation | Injury, poisoning and procedural complications | Glimepiride | 1 | 61 | 1 |
| serious | Rib fracture | Injury, poisoning and procedural complications | Dapagliflozin | 1 | 60 | 1 |
| serious | Rib fracture | Injury, poisoning and procedural complications | Glimepiride | 0 | 61 | 0 |
| serious | Splenic injury | Injury, poisoning and procedural complications | Dapagliflozin | 1 | 60 | 1 |
| serious | Splenic injury | Injury, poisoning and procedural complications | Glimepiride | 0 | 61 | 0 |
| serious | Subdural haemorrhage | Injury, poisoning and procedural complications | Dapagliflozin | 1 | 60 | 1 |
| serious | Subdural haemorrhage | Injury, poisoning and procedural complications | Glimepiride | 0 | 61 | 0 |
| serious | Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | Dapagliflozin | 1 | 60 | 1 |
| serious | Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | Glimepiride | 0 | 61 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02564926/events